Operating Margin in % of RIGEL PHARMACEUTICALS INC from 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Operating Margin history and change rate from 2016 to Q3 2025.
  • Rigel Pharmaceuticals Inc Operating Margin for the quarter ending September 30, 2025 was 42.2 %, a 599% increase year-over-year.
  • Rigel Pharmaceuticals Inc annual Operating Margin for 2024 was 13.5 %.
  • Rigel Pharmaceuticals Inc annual Operating Margin for 2023 was -17.5 %, a 62.1% increase from 2022.
  • Rigel Pharmaceuticals Inc annual Operating Margin for 2022 was -46.2 %, a 452% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

RIGEL PHARMACEUTICALS INC Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 42.2 +36.1 +599% Jul 1, 2025 Sep 30, 2025
Q2 2025 39 +46 Apr 1, 2025 Jun 30, 2025
Q1 2025 21.6 +33.9 Jan 1, 2025 Mar 31, 2025
Q4 2024 13.5 +31 Oct 1, 2024 Dec 31, 2024
Q3 2024 6.03 +21.4 Jul 1, 2024 Sep 30, 2024
Q2 2024 -6.92 +20.2 +74.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -12.2 +20.2 +62.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -17.5 +28.7 +62.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -15.4 +73.1 +82.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -27.1 +63.8 +70.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -32.4 +62.4 +65.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -46.2 -37.8 -452% Oct 1, 2022 Dec 31, 2022
Q3 2022 -88.5 -81.7 -1215% Jul 1, 2022 Sep 30, 2022
Q2 2022 -90.9 -88.2 -3257% Apr 1, 2022 Jun 30, 2022
Q1 2022 -94.8 -88.6 -1439% Jan 1, 2022 Mar 31, 2022
Q4 2021 -8.37 +18.3 +68.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -6.73 +19.3 +74.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -2.71 +21.1 +88.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -6.16 +22.8 +78.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -26.7 +89.9 +77.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -26 +34.2 +56.8% Jul 1, 2020 Sep 30, 2020
Q2 2020 -23.8 +69.8 +74.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 -29 +87.1 +75% Jan 1, 2020 Mar 31, 2020
Q4 2019 -117 Oct 1, 2019 Dec 31, 2019
Q3 2019 -60.2 Jul 1, 2019 Sep 30, 2019
Q2 2019 -93.6 Apr 1, 2019 Jun 30, 2019
Q1 2019 -116 Jan 1, 2019 Mar 31, 2019

RIGEL PHARMACEUTICALS INC Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 13.5 +31 Jan 1, 2024 Dec 31, 2024
2023 -17.5 +28.7 +62.1% Jan 1, 2023 Dec 31, 2023
2022 -46.2 -37.8 -452% Jan 1, 2022 Dec 31, 2022
2021 -8.37 +18.3 +68.6% Jan 1, 2021 Dec 31, 2021
2020 -26.7 +89.9 +77.1% Jan 1, 2020 Dec 31, 2020
2019 -117 +46.8 +28.6% Jan 1, 2019 Dec 31, 2019
2018 -163 +1.61K +90.8% Jan 1, 2018 Dec 31, 2018
2017 -1.78K -1.43K -419% Jan 1, 2017 Dec 31, 2017
2016 -342 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.